Probable association between mRNA COVID-19 vaccine and opsoclonus-myoclonus-ataxia syndrome

We report the case of a 15-year-old girl who developed OMAS 24 hours after her first dose of mRNA COVID-19 (BioNTech) vaccine.

Source: Journal of AAPOS - January 30, 2023 Category: Opthalmology Authors: Adnan Deniz, Defne Alik ılıç, Merve Öztürk, Ömer Karaca, Mesut Güngör, Bülent Kara Tags: Short Report Source Type: research